Immune Response Settles Shareholder Suits
The Immune Response Corp. said Tuesday that it will pay nearly $10 million to settle a pair of securities class action lawsuits that accused it of misrepresenting the efficacy of its...To view the full article, register now.
Already a subscriber? Click here to view full article